Freestone Grove Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Sell
14,136
-153,219
-92% -$20.1M 0.01% 395
2025
Q4
$22.8M Sell
167,355
-20,547
-11% -$2.96M 0.16% 186
2025
Q3
$27.7M Buy
187,902
+175,345
+1,396% +$24.3M 0.21% 164
2025
Q2
$1.62M Sell
12,557
-164,495
-93% -$19.9M 0.01% 389
2025
Q1
$21.2M Buy
+177,052
New +$21.9M 0.22% 158

Other funds holding XYL

Freestone Grove Partners's XYL Position: Q1 2026 in Review

Freestone Grove Partners reduced its Xylem (XYL) stake by 92% in Q1 2026, selling an estimated $20.1M and leaving 14,136 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #395.

Freestone Grove Partners first reported a position in XYL in Q1 2025 and has held it in 5 quarters since. The position peaked at $27.7M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Freestone Grove Partners held 14,136 shares of Xylem worth $1.69M as of Q1 2026.
  • Freestone Grove Partners sold 153,219 Xylem shares in Q1 2026, an estimated $20.1M.
  • Xylem made up 0.01% of Freestone Grove Partners's portfolio in Q1 2026, its #395 holding.
  • Freestone Grove Partners first reported a position in Xylem in Q1 2025 and has held it in 5 quarters since.
  • Freestone Grove Partners's Xylem position peaked at $27.7M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.